INCYTE CORP Annual Income Tax Expense (Benefit) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Incyte Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2012 to 2023.
  • Incyte Corp Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $50.1M, a 19.9% decline year-over-year.
  • Incyte Corp Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $241M, a 10.3% increase year-over-year.
  • Incyte Corp annual Income Tax Expense (Benefit) for 2023 was $237M, a 25.6% increase from 2022.
  • Incyte Corp annual Income Tax Expense (Benefit) for 2022 was $188M.
  • Incyte Corp annual Income Tax Expense (Benefit) for 2021 was -$378M, a 696% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $237M +$48.2M +25.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-13
2022 $188M +$567M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-13
2021 -$378M -$442M -696% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-13
2020 $63.5M +$23.6M +59.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-07
2019 $39.9M +$34M +581% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-08
2018 $5.85M +$5M +587% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-09
2017 $852K -$2.33M -73.2% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-13
2016 $3.18M +$2.16M +210% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-14
2015 $1.03M +$1.09M Jan 1, 2015 Dec 31, 2015 10-K 2018-02-15
2014 -$66K -$365K -122% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-14
2013 $299K +$125K +71.8% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-12
2012 $174K Jan 1, 2012 Dec 31, 2012 10-K 2015-02-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.